Skip to main content
. 2024 May 12;15:116. doi: 10.1186/s13244-024-01689-6

Table 3.

The risk-scoring system for the prognosis prediction in LAPC patients assessed as SD

Evaluations Scores
CA19-9 response
  Present 0
  Absent 2
Rim-enhancement
  Absent 0
  Present 1
ECV
 ≥ 20% −2
 16–20% 0
 < 16% 1
Peripancreatic fat infiltration
  Absent 0
  Present 1

CA19-9 carbohydrate antigen 19-9, ECV tumor extracellular volume, SD stable disease